Abstract:Background The growth and metastasis of tumors depend on the development of an adequate blood supply via angiogenesis. Recent studies indicate that the inducible nitric oxide synthase (iNOS), vascular endothelial growth factor (VEGF) and the tumor suppressor p53 are fundamental play-markers of the angiogenic process. Overexpression of iNOS and VEGF has been shown to induce angiogenesis in tumors. P53 suppresses angiogenesis by down-regulating VEGF and iNOS. The correlation of expression of p53, VEGF and iNOS and clinical features in gastric carcinogenesis, however, has not been well characterized. Methods The expression of p53, iNOS and VEGF in gastric precancerous and cancerous lesions and its relation with the clinical features was determined with immunohistochemistry (avidin-biotin-peroxidase complex method) on 55 randomly selected GC patients and 60 symptom-free subjects from the mass survey in the high-incidence area for GC in Henan, northern China. Results The positive immunostainig rates for p53, iNOS and VEGF in gastric carcinomas were 51%, 44% and 51%, respectively, and correlated well with TNM stages, but did not show significant difference among the groups with different degrees of gastric wall invasion depth by GC. A positive immunostaining reaction for the iNOS protein was significantly correlated with lymph node metastasis (p = 0.019; Spearman correlation coefficient). P53 protein accumulation was higher in the poorly-differentiated gastric carcinoma than in well-differentiated one. In gastric biopsies, no positive immunosatining was observed for p53, iNOS and VEGF in the histologically normal tissue and chronic superficial gastritis (CSG). However, p53, iNOS and VEGF positive immunostaining was observed in the tissues with different severities of lesions of chronic atrophic gastritis (CAG), intestinal metaplasia (IM) and dysplasia (DYS), and the positive rates increased with the lesion progression from CAG to IM to DYS. A high coincidental positive and negative immunostaining rate for p53, iNOS and VEGF was observed both in biopsy samples with CAG, IM and DYS from the symptom-free subjects and in gastric cancer tissue from the GC patients. Conclusions The present results indicated that p53 protein accumulation and increased expression of iNOS and VEGF might be responsible for gastric carcinogenesis and tumor aggressiveness of gastric cancer.

Expression of estrogen inducing gene PS2/TFF1 in gastric cancer and precancerous lesions

Expression of Trefoil Factors 1 and 2 in Precancerous Condition and Gastric Cancer

[The Expression of Trefoil Factor 1 and Trefoil Factor 2 in Gastric Cancer and Precancer].

Study on Expression of pS2/TFF1 Protein in Gastric Cancer and Precancerous Lesion

Expression of PTEN Protein in Gastric Carcinoma, Adjacent Mucosa and Precancerous Lesions of Stomach and Its Significance

TFF2 Expression and H. Pylori Infection in Gastric Cancer Tissues

TFF1 Inhibits Proliferation and Induces Apoptosis of Gastric Cancer Cells in Vitro.

Expression of TFF2 Andhelicobacter Pyloriinfection in Carcinogenesis of Gastric Mucosa

Expressions and Clinical Significance of TGF-β1,TGF-βRII,Smad2/3 and CDC25 in Gasrtic Carcinoma

Expressions of mutant p53,Mdm2 and PCNA protein in gastric mucosal lesions and their relationship with Helicobacter pylori infection

The expression of NOD2 and TLR9 in gastric carcinoma and precancerous lesions

Expression of P53, Inducible Nitric Oxide Synthase and Vascular Endothelial Growth Factor in Gastric Precancerous and Cancerous Lesions: Correlation with Clinical Features

Expression of Tumor-Associated Glycoprotein 72(tag72)and Glucose-Regulated Protein 94(grp94)and Their Clinicopathological Significances in Benign and Malignant Lesions of Stomach

Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.

Expression of SENP1 and P53 Proteins in Gastric and Cancer Its Significance

Altered Expression of Selenium-Binding Protein 1 in Gastric Carcinoma and Precursor Lesions

Association of expressions of hTERT mRNA and p53 protein in gastric mucosal lesions with Helicobacter pylori infection

Expression of the Tumor Susceptibility Gene(TSG101) in Carcinoma of Esophagus, Stomach and Colorectum

Study on the expression of pituitary tumor-transforming(PTTG) and fragile histidine triad(FHIT) in gastric cancer and pericancerous tissues

The Expression and Clinical Significance of EZH2 and P53 Protein in Gastric Carcinoma

Expression of Tissue Factor Pathway Inhibitor-2 in Gastric Stromal Tumor and Its Clinical Significance